BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Spectral Medical Inc.

Headquarters: Toronto, ON, Canada
Year Founded: 1991
Status: Public
Industry Sector: HealthTechnology
CEO: Chris Seto, MBA
Number Of Employees: 29
Enterprise Value: $93,584,809
PE Ratio: -6.14
Exchange/Ticker 1: TSX:EDT
Exchange/Ticker 2: OTCQB:EDTXF
Latest Market Cap: $110,681,065

BioCentury | Oct 18, 2017
Company News

Management tracks: Gilead, Ipsen, Depomed

BioCentury | Jan 6, 2017
Clinical News

Toraymyxin: Ph III EUPHRATES data

BioCentury | Jan 6, 2017
Finance

Tiers of disappointment

Bad year for biotech ends on sour note in 4Q16 with all market cap tiers in red
BioCentury | Jul 11, 2016
Company News

Spectral Medical sales and marketing update

BioCentury | Jun 27, 2016
Clinical News

Toraymyxin: Completed Phase III enrollment

BioCentury | Feb 29, 2016
Financial News

Spectral Medical financial update

BioCentury | Feb 22, 2016
Financial News

Spectral Medical completes follow-on

BioCentury | Feb 1, 2016
Financial News

Spectral Medical proposes follow-on

BioCentury | Mar 23, 2015
Financial News

Spectral Medical completes private placement

BioCentury | Mar 23, 2015
Clinical News

Toraymyxin: Phase III ongoing

Items per page:
1 - 10 of 10
Help Center
Username
Request a Demo
Request Training
Ask a Question